Total Jobs Filled:
Our relationship with Barrier Therapeutics began in 2004.
Vice President, Supply Chain (60-day placement) (Currently a GM and client)
Director, Business Development
Director, International Regulatory Affairs
Director, US Regulatory Affairs
Vice President, Business Development
In 2008, Barrier was acquired for $150 million.
Our placement as the EVP R&D became a CEO of a specialty pharma company.